Market Impact & Expansion
Targeting the Global Market
Cancer is one of the leading causes of death worldwide, and there is a growing demand for more accessible and affordable treatments. At CCTBH AB, we are strategically positioned to meet this demand, particularly in regions such as China, where breast cancer incidence is high. Our PRFA device is designed to cater to the needs of a target population of over 96,000 breast cancer patients in regions with a GDP per capita above $15,000.
Expanding in Key Markets
China represents a massive market opportunity for CCTBH. With a population of over 500 million residents in regions with higher incomes, our cancer treatment solution can be rapidly adopted. In urban areas where breast cancer incidence is higher, our device offers an efficient, cost-effective option for treatment, filling a critical gap in current healthcare solutions.
Regional Differences in Cancer Treatment Access
One of the challenges we aim to address is the disparity in cancer treatment access between urban and rural areas. CCTBH AB is committed to bridging this gap by offering a flexible, scalable solution that can be easily implemented in both high-tech urban hospitals and smaller rural clinics, making effective treatment accessible to a broader audience.
Projected Growth
We aim to achieve 5% market penetration in our first three years, with a goal of reaching 10% penetration within five years. Our plan includes producing 50 machines annually, targeting areas with the highest demand for innovative breast cancer treatment. With the right partnerships and support, we are confident in achieving these ambitious goals and changing the landscape of cancer care in the region.
